Unexpectedly, induction of cytotoxic T lymphocytes enhances the humoral response after DNA immunization

被引:5
作者
Dyer, CM
Zhan, YF
Brady, JL
Carbone, FR
Smyth, MJ
Lew, AM
机构
[1] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia
[2] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia
[3] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia
关键词
D O I
10.1182/blood-2003-07-2305
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although there are many examples (eg, immune deviation) in which enhanced cellular responses correspond with lower humoral responses, here we demonstrate for the first time 2 models in which cytotoxic T-lymphocyte (CTL) activity is associated with an enhanced antibody response. First, C57BL/6 mice generate a stronger antibody response to ovalbumin DNA immunization than congenic bm1 mice. The latter differ from C57BL/6 mice in that the H-2K(b) molecule is mutated so that the immunodominant CTL epitope of ovalbumin is no longer presented. Second, pre-existing CTLs (induced by ovalbumin peptide-priming) increased the antibody response to a second unrelated antigen (P-galactosidase) co-immunized with ovalbumin. One possible mechanism is that CTLs may release antigen from DNA-transfected cells by killing or damaging them, and this freed antigen is then accessible to dendritic cells and B cells. Our finding of CTL-mediated antibody enhancement has important implications for tumor and viral immunoblology and vaccination.
引用
收藏
页码:3073 / 3075
页数:3
相关论文
共 22 条
[1]   Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs [J].
Albert, ML ;
Sauter, B ;
Bhardwaj, N .
NATURE, 1998, 392 (6671) :86-89
[2]   Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].
Amara, RR ;
Villinger, F ;
Altman, JD ;
Lydy, SL ;
O'Neil, SP ;
Staprans, SI ;
Montefiori, DC ;
Xu, Y ;
Herndon, JG ;
Wyatt, LS ;
Candido, MA ;
Kozyr, NL ;
Earl, PL ;
Smith, JM ;
Ma, HL ;
Grimm, BD ;
Hulsey, ML ;
Miller, J ;
McClure, HM ;
McNicholl, JM ;
Moss, B ;
Robinson, HL .
SCIENCE, 2001, 292 (5514) :69-74
[3]   ENHANCEMENT OF DISEASE BY NEUTRALIZING ANTIVIRAL ANTIBODIES IN THE ABSENCE OF PRIMED ANTIVIRAL CYTOTOXIC T-CELLS [J].
BATTEGAY, M ;
KYBURZ, D ;
HENGARTNER, H ;
ZINKERNAGEL, RM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (12) :3236-3241
[4]   DNA immunization: Induction of higher avidity antibody and effect of route on T cell cytotoxicity [J].
Boyle, JS ;
Silva, A ;
Brady, JL ;
Lew, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) :14626-14631
[5]   DETERMINANT SELECTION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED ANTIGENIC PEPTIDES IS EXPLAINED BY CLASS I-PEPTIDE AFFINITY AND IS STRONGLY INFLUENCED BY NONDOMINANT ANCHOR RESIDUES [J].
CHEN, WS ;
KHILKO, S ;
FECONDO, J ;
MARGULIES, DH ;
MCCLUSKEY, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1471-1483
[6]   Viral escape from the neutralizing antibody response: the lymphocytic choriomeningitis virus model [J].
Ciurea, A ;
Hunziker, L ;
Zinkernagel, RM ;
Hengartner, H .
IMMUNOGENETICS, 2001, 53 (03) :185-189
[7]   DNA-based immunization by in vivo transfection of dendritic cells [J].
Condon, C ;
Watkins, SC ;
Celluzzi, CM ;
Thompson, K ;
Falo, LD .
NATURE MEDICINE, 1996, 2 (10) :1122-1128
[8]   SWITCH OF CD8 T-CELLS TO NONCYTOLYTIC CD8-CD4- CELLS THAT MAKE T(H)2 CYTOKINES AND HELP B-CELLS [J].
ERARD, F ;
WILD, MT ;
GARCIASANZ, JA ;
LEGROS, G .
SCIENCE, 1993, 260 (5115) :1802-1805
[9]   Cross-presentation in viral immunity and self-tolerance [J].
Heath, WR ;
Carbone, FR .
NATURE REVIEWS IMMUNOLOGY, 2001, 1 (02) :126-134
[10]   Enhancing efficacy of recombinant anticancer vaccines with prime/boost regimens that use two different vectors [J].
Irvine, KR ;
Chamberlain, RS ;
Shulman, EP ;
Surman, DR ;
Rosenberg, SA ;
Restifo, NP .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (21) :1595-1601